— Know what they know.
Not Investment Advice

PSYBF OTC

PsyBio Therapeutics Corp
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: -90.0% 3Y: -100.0% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 49 · $1275 mcap · 84M float · 0.0083% daily turnover
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.0M
52W Range0.000001-0.005
Volume8,000
Avg Volume6,950
Beta0.49
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOEvan Levine
Employees118
SectorHealthcare
IndustryBiotechnology
IPO Date2021-04-23
1624 Washington Street
Denver, CO 80203
US
513 449 9585
About PsyBio Therapeutics Corp

PsyBio Therapeutics Corp. engages in the development of drugs intended for the treatment of mental health challenges and other disorders. The company was founded on October 28, 2009 and is headquartered in Sunrise, FL.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms